This inventor holds 1 USPTO granted patent. Top assignee: Council of Scientific and Industrial Research. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Subrata Das: Innovator in Non-Alcoholic Fatty Liver Disease Treatment
Introduction
Subrata Das is a notable inventor based in Kolkata, India. He has made significant contributions to the field of medical research, particularly in the treatment of non-alcoholic fatty liver disease (NAFLD). His innovative work has led to the development of compounds that offer potential therapeutic benefits.
Latest Patents
Subrata Das holds a patent for "Quinazolinones derivatives for treatment of non-alcoholic fatty liver disease, preparation and use thereof." This patent describes compounds that inhibit or modulate the Ubiquitin Ligase COP1 enzyme, which can produce a physiologically beneficial response. Specifically, these compounds are designed to treat NAFLD by increasing the level of adipose triglyceride lipase (ATGL). The patent also outlines the process for preparing these compounds, showcasing his commitment to advancing medical science.
Career Highlights
Subrata Das is affiliated with the Council of Scientific and Industrial Research, where he continues to engage in groundbreaking research. His work is characterized by a focus on innovative solutions to complex health issues, particularly those related to liver diseases.
Collaborations
Some of his coworkers include Saheli Chowdhury and Nirmal Das, who contribute to his research efforts and collaborative projects.
Conclusion
Subrata Das is a prominent inventor whose work in developing treatments for non-alcoholic fatty liver disease exemplifies the impact of innovation in healthcare. His contributions are paving the way for new therapeutic options and improving patient outcomes.